Freund John Gordon — SEC Form 4 filings
SEC reporting owner CIK 1296771. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-16 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 34,539 shares, $940,015 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 11,659 shares @ $34.36 ($400,641) in COLLEGIUM PHARMACEUTICAL, INC, filed 2025-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | 6 | — | 4 legs · 22,407 sh · $746,017 | 7 |
| SI-BONE, Inc. (SIBN) | Director | 4 | — | 1 leg · 12,132 sh · $193,998 | 3 |
| SUTRO BIOPHARMA, INC. (STRO) | Director | 1 | — | — | 1 |
Form 4 filings — Freund John Gordon
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | SI-BONE, Inc. (SIBN) | Grant/award (A): 10,957 @ $0 | EDGAR |
| 2026-05-20 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale (S): 20 @ $34.05 | EDGAR |
| 2026-05-18 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 8,741 @ $0 · Option exercise (M): 8,700 @ $16.49 · Sale (S): 4,127 @ $34.54 · Option exercise (M): 8,700 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale (S): 11,659 @ $34.36 | EDGAR |
| 2025-08-11 | 4 | SI-BONE, Inc. (SIBN) | Sale (S): 12,132 @ $15.99 | EDGAR |
| 2025-06-11 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Option exercise (M): 15,000 @ $13.45 · Sale (S): 6,601 @ $30.62 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | SI-BONE, Inc. (SIBN) | Grant/award (A): 8,675 @ $0 | EDGAR |
| 2025-05-19 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 9,791 @ $0 | EDGAR |
| 2024-06-27 | 4 | SI-BONE, Inc. (SIBN) | Grant/award (A): 8,791 @ $0 | EDGAR |
| 2024-06-10 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 7,693 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1296771 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →